NBIX vs OBT · P/E 45, rev $1.77B vs P/E 11, rev $69.0M
Neurocrine Biosciences Inc (NBIX) versus Orange County Bancorp Inc (OBT) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Orange County Bancorp Inc (OBT) is a banks - regional company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported OBT revenue for 2026-06-30 was $69.0M. Net income was $24.9M. OBT currently screens at market cap $345.3M and trailing P/E 10.7.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. OBT currently screens at market cap $345.3M and trailing P/E 10.7.
Not investment advice. Open the NBIX and OBT stock pages for the full models.
Not investment advice.